Compare VANI & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VANI | RVSB |
|---|---|---|
| Founded | 1998 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | 106.9M |
| IPO Year | 2014 | 1997 |
| Metric | VANI | RVSB |
|---|---|---|
| Price | $1.43 | $5.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.50 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 166.8K | 56.3K |
| Earning Date | 05-14-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | ★ $4,000,000.00 | N/A |
| Revenue This Year | N/A | $53.63 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $64.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $4.74 |
| 52 Week High | $1.92 | $6.22 |
| Indicator | VANI | RVSB |
|---|---|---|
| Relative Strength Index (RSI) | 52.89 | 42.96 |
| Support Level | $1.26 | $5.02 |
| Resistance Level | $1.55 | $5.56 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 43.23 | 48.48 |
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
Riverview Bancorp Inc is the bank holding company. The Company's operations are managed along two operating segments, consisting of banking operations performed by the Bank and trust and investment services performed by the Trust Company. The Bank is engaged mainly in the business of attracting deposits from the general public and using such funds, together with other borrowings, to make various commercial business, commercial real estate, land, multi-family real estate, real estate construction and consumer loans. Additionally, the Trust Company offers trust and investment services. It has single operating segment.